Sectra Acquires Oxipit to Boost Autonomous AI in Radiology

Event summary

  • Sectra acquires Oxipit, a Lithuanian AI radiology specialist, for an undisclosed sum, with the deal expected to close in March 2026.
  • Oxipit's ChestLink holds the first CE Class IIB certification for autonomous AI in chest X-ray analysis.
  • The acquisition aims to enhance Sectra's AI capabilities, addressing rising imaging volumes and workforce constraints.
  • Oxipit's team will operate as a dedicated AI development center within Sectra's Imaging IT Solutions.
  • The deal is financed using Sectra's own funds and includes contingent consideration linked to commercial and regulatory milestones.

The big picture

The acquisition positions Sectra at the forefront of autonomous AI in radiology, addressing critical industry challenges such as rising imaging volumes and workforce shortages. By integrating Oxipit's CE Class IIB-certified ChestLink, Sectra aims to enhance its AI ecosystem, potentially setting a new standard for autonomous diagnostic tools in healthcare. The deal underscores the growing importance of AI-driven solutions in improving efficiency and safety in medical imaging.

What we're watching

Regulatory Expansion
Whether Sectra can secure regulatory approvals to expand ChestLink's availability beyond the EEA.
Workforce Efficiency
How the integration of autonomous AI will impact radiologist workload and productivity.
Market Competition
The pace at which competitors adopt similar autonomous AI solutions in diagnostic imaging.

Related topics

Acquisition